EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist

Nicole L De La Mata iD, Victor Khou iD, James A Hedley iD, Patrick J Kelly iD, Rachael L Morton iD, Kate Wyburn iD, Angela C Webster iD

Nephrology Dialysis Transplantation · 2024

DOI: 10.1093/ndt/gfad253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Nicole L De La Mata und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia. Hauptthemen laut MEDLINE: Waiting Lists, Kidney Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

People on the kidney waitlist are less informed about potential suspensions. Disparities may exist among those who are suspended and who return to the waitlist. We evaluated the patient journey after entering the waitlist, including suspensions and outcomes, and factors associated with these transitions.

Methods

We included all incident patients waitlisted for their first transplant from deceased donors in Australia from 2006 to 2019. We described all clinical transitions after entering the waitlist. We predicted the restricted mean survival time (unadjusted and adjusted) until first transplant by the number of prior suspensions. We evaluated factors associated with transitions using flexible survival models and clinical endpoints using Cox models.

Results

Of 8466 patients waitlisted and followed over 45 757.4 person-years (median 4.8 years), 6741 (80%) were transplanted, 381 (5%) died waiting and 1344 (16%) were still waiting. A total of 3127 (37%) people were suspended at least once. Predicted mean time from waitlist to transplant was 3.0 years [95% confidence interval (CI) 2.8–3.2] when suspended versus 1.9 years (95% CI 1.8–1.9) when never suspended. Prior suspension increased the likelihood of further suspensions 4.2-fold (95% CI 3.8–4.6) and returning to the waitlist by 50% (95% CI 36–65) but decreased the likelihood of transplantation by 29% (95% CI 62–82). Death risk while waiting was increased 12-fold (95% CI 8.0–18.3) when currently suspended. Australian non-Indigenous males were 13% [hazard ratio (HR) 1.13 (95% CI 1.04–1.23)] and Asian males 23% [HR 1.23 (95% CI 1.06–1.42)] more likely to return to the waitlist compared with females of the same ethnicity.

Conclusion

The waitlist journey was not straightforward. Suspension was common, impacted the chance of transplantation and meant waiting an average of 1 year longer until transplant. We have provided estimates for and factors associated with suspension, relisting and outcomes after waitlisting to support more informed discussions. This evidence is critical to further understand drivers of inequitable access to transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Waiting ListsKidney TransplantationHumansMaleFemaleAustraliaMiddle AgedAdultKidney Failure, ChronicTissue and Organ ProcurementSurvival RateAged

Stichwörter der Autor:innen

Australiakidney waitlistoutcomesrelistingsuspension

Autor:innen und Institutionen

  • Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
  • NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
  • Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
  • Renal Department, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Centre for Renal and Transplant Research, Westmead Hospital, Sydney, NSW, Australia.

ORCID-Profile: Nicole L De La Mata, Victor Khou, James A Hedley, Patrick J Kelly, Rachael L Morton, Kate Wyburn, Angela C Webster

Förderung

  • National Health and Medical Research Council

Zitieren

APA

De La Mata, N. L., Khou, V., Hedley, J. A., Kelly, P. J., Morton, R. L., Wyburn, K., & Webster, A. C. (2024). Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad253

Vancouver

De La Mata NL, Khou V, Hedley JA, Kelly PJ, Morton RL, Wyburn K, et al. Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfad253

BibTeX
@article{DeLaMata2024,
  author = {De La Mata, Nicole L and Khou, Victor and Hedley, James A and Kelly, Patrick J and Morton, Rachael L and Wyburn, Kate and Webster, Angela C},
  title = {Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  doi = {10.1093/ndt/gfad253}
}
Kostenlos starten →